Publications
Short Communication: Adjuvant 5-Fluorouracil and Folinic Acid versus Observation for Pancreatic Cancer: Composite Data from the ESPAC-1 and -3(v1) Trials.
Authors: Neoptolemos JP, Stocken DD, Tudur Smith C, Bassi C, Ghaneh P, Owen E, Moore M, Padbury R, Doi R, Smith D, Büchler MW for the European Study Group of Pancreatic Cancer
Journal: British Journal of Cancer 2009; Jan 27;100(2):246-50. Epub 2009 Jan 6
Authors: Ross Carter, Deborah D. Stocken, Payla Ghaneh, Simon R. Bramhall, Attila Olah, Deszo Kelemen, Claudio Bassi,\r\nHelmut Friess, Christo Dervenis, Nigel Spry, Markus W. B€uchler, and John P. Neoptolemos, for the European Study\r\nGroup for Pancreatic Cancer (ESPAC)
Journal: International Journal of Cancer;
Authors: Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JHG, Bakkevold KE, Takada T, Amano H, Dervenis C, Bassi C, Büchler MW, Neoptolemos JP, on behalf of the Pancreatic Cancer Meta-analysis Group
Journal: Archives of Surgery 2008; 143(1):75-83
The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.
Authors: Smith R, Sutton R, Evans J, Healey P, Garvey C, Hughes M, Rararty M, Campbell F, Neoptolemos JP
Journal: Surgery 2008;; 143(5): 658-66
Authors: Smith RA, Dajani K, Dodd S, Whelan P, Raraty M, Sutton R, Campbell F, Neoptolemos JP, Ghaneh P
Journal: Ann Surg Oncol. 2008; 15(11): 3138-46
Authors: Sultana A, Ghaneh P, Cunningham D, Starling N, Neoptolemos JP, Smith CT
Journal: BMC Cancer. 2008; Jul 8;8:192
Clinical evidence does not support the use of adjuvant radiotherapy in pancreatic cancer.
Authors: Neoptolemos JP
Journal: Nat Clin Pract Oncol 2008; 5: 431-431
Authors: Smith RA, Bosonnet L, Ghaneh P, Raraty M, Sutton R, Campbell F, Neoptolemos JP
Journal: Dig Surg. 2008; 25(3):226-32. Epub 2008 Jun 24
Authors: Ghaneh P, Smith R, Tudor-Smith C, Raraty M, Neoptolemos JP
Journal: Eur J Surg Oncol. 2008; 34(3):297-305
Authors: Alexakis N, Neoptolemos JP
Journal: Best Pract Res Clin Gastroenterol. 2008; 22(1):183-205
Authors: Neoptolemos JP
Journal: Nat Clin Pract Oncol. 2008; Aug;5(8):431
New treatment options for advanced pancreatic cancer.
Authors: Middleton G, Ghaneh P, Costello E, Greenahlf W, Neoptoelmos JP
Journal: Expert Rev Gastroenterol Hepatol. 2008; 2(5):673-696
Authors: Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP
Journal: J Gastrointest Surg. 2008; Aug;12(8):1422-8. Epub 2008 Jun 10
Authors: Diener MK, Knaebel HP, Witte ST, Rossion I, Kieser M, Buchler MW, Seiler CM; DISPACT Trial Group
Journal: Clin Trials. 2008; 5(5):534-45
Delayed gastric emptying after pancreatic surgery – A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS).
Authors: Wente MN, Claudio Bassi, Christos Dervenis, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo, CJ, Büchler MW
Journal: Surgery 2007; 142(5): 761-8
Postpancreatectomy hemorrhage (PPH) – An International Study Group of Pancreatic Surgery (ISGPS) definition.
Authors: Wente MN, Veit JA,Claudio Bassi, Christos Dervenis, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo, CJ, Büchler MW
Journal: Surgery 2007; 142(1):20-5
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer.
Authors: Sultana A, Tudur Smith C, Cunningham D, Starling N, Neoptolemos JP, Ghaneh P
Journal: Journal of Clinical Oncology 2007; 20; 25(18):2607-15
Meta-analyses on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.
Authors: Sultana A, Tudur Smith C, Cunningham D, Starling N, Tait D, Neoptolemos JP, Ghaneh P
Journal: British Journal of Cancer 2007; 96: 1183-90
Recent advances in Clinical Practice. Advances in counselling and surveillance of patients at risk for pancreatic cancer.
Authors: Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI, Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas
Journal: Gut, 2007; 56:1460-1469
Adjuvant Chemotherapy – the standard after resection for Pancreatic Cancer.
Authors: Ghaneh P, Neoptolemos JP
Journal: American Journal of Surgery 2007; 194:S131-137
Authors: Aung KL, Smith DB, Neoptolemos JP
Journal: Expert Opin Pharmacother. 2007; 8(15):2533-41
Authors: Ghaneh P, Tudur-Smith C, Neoptolemos JP
Journal: Drugs. 2007; 67(17):2487-90
Capecitabine in carcinoma of the pancreas.
Authors: Smith DB, Neoptolemos JP
Journal: Expert Opinions in Pharmacotherapy 2006; 7(12):1633-9
The case for adjuvant chemotherapy in pancreatic cancer.
Authors: Ghaneh P, Sultana A, Shore S, Stocken D, Neoptolemos J
Journal: Best Practice Research Clinical Gastroenterology 2006; 20(2):383-401
Role of erlotinib in the management of pancreatic cancer.
Authors: Starling N, Neoptolemos J, Cunningham D
Journal: Therapeutics and Clinical Risk Management. 2006; 2 (4): 435-445
Authors: Sultana A, Neoptolemos J, Ghaneh P
Journal: HPB (Oxford). 2006; 8 (5):352-64
Guidelines for the management of patients with pancreatic cancer peri‑ampullary and ampullary carcinomas.
Authors: Alderson D, Johnson CD, Neoptolemos JP, Ainley CC, Bennett MK, Campbell F, Charnley RM, Corrie PG, Falk SJ, Foulis AK, Hall RI, Hacking CN, Imrie CW, Kennedy RH, Kingsnorth AN, Lendrum R, Longstaff AJ, Manson J McK, Mitchell CJ, Russell RCG, Thomas WEG on behalf of the Writing Committee established by the Pancreatic Section of the British Society of Gastroenterology with the participation of the Pancreatic Society of Great Britain & Ireland, the Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland, the Royal College of Pathologists, the Special Interest Group for Gastro-Intestinal Radiology
Journal: Gut 2005; 54(Suppl V):v1-v16
Serum CA 19-9 measurement increases the effectiveness of staging laparoscopy in patients with peri-ampullary malignancy.
Authors: Connor S, Bosonnet L, Alexakis N, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP
Journal: Digestive Surgery 2005; 22(1-2):80-85
Positron Emission Tomography does not add to Computed Tomography for the diagnosis and staging of pancreatic cancer.
Authors: Lytras D, Connor S, Bosonnet L, Jayan R, Evans J, Hughes M, Garvey CJ, Ghaneh P, Sutton R, Vinjamuri S, Neoptolemos JP
Journal: Digestive Surgery 2005; 22(1-2):55-61
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
Authors: Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JHG, Bakkevold KE, Takada T, Amano H, Neoptolemos JP on behalf of the Pancreatic Cancer Meta-analysis Group
Journal: British Journal of Cancer 2005; 92(8):1372-81
Post-operative pancreatic fistula: an International Study Group (ISGPF) definition.
Authors: Bassi C, Butturini G, Fingerhut A, Yeo C, Izibicki J, Neoptolemos JP, Sarr M, Traverso W, Buchler M, Dervenis C for the International Study Group on Pancreatic Fistula Definition
Journal: Surgery 2005; 138(1):8-13
The Influence of Surgical Resection and Post-operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial.
Authors: Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H, Dervenis C, Dunn JA, Deakin M, Carter R, Ghaneh P, Neoptolemos JP, Büchler MW
Journal: Digestive Surgery 2005; 22(5):353-363
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Authors: Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW for the members of the European Study Group for Pancreatic Cancer (ESPAC)
Journal: New England Journal of Medicine 2004; 350(12):1200-1210
Current standards of surgery for pancreatic cancer.
Authors: Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP
Journal: British Journal of Surgery 2004; 91:1410-27
Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Authors: Ghaneh P, Neoptolemos JP
Journal: Surgical Oncology Clinics of \r\n North America 2004; 13(4):567-87
CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas.
Authors: Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, Neoptolemos JP
Journal: American Journal of Roentgenology 200; 3; 180: 475-80
Adjuvant and additive therapy for cancer of the pancreas. [Article in German].
Authors: Neoptolemos JP, Raraty MG, Ghaneh P, Hickey H, Stocken DD, Dunn JA, Friess H, Buchler MW
Journal: Chirurg 2003; 74:191-201
Adjuvant therapy in pancreatic cancer: historical and current perspectives.
Authors: Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, Dunn JA, Dervenis C, Lacaine F, Hickey H, Raraty MG, Ghaneh P, Buchler MW
Journal: Annals of Oncology 2003; 14(5): 675-692
Chemotherapy for pancreatic cancer.
Authors: Shore S, Raraty MG, Ghaneh P, Neoptolemos JP
Journal: Aliment Pharmacol Ther 2003; 18(11-12):1049-69
New techniques and agents in the adjuvant therapy of pancreatic cancer.
Authors: Raraty MG, Magee CJ, Ghaneh P, Neoptolemos JP
Journal: Acta Oncol 2002; 41(7-8):583-595
Detailed tissue expression of BCL-2, BAX, BAK, and BCL-X in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.
Authors: Evans JD, Cornford PA, Dodson A, Greenhalf W, Foster CS, Neoptolemos JP
Journal: Pancreatology 2001; 1: 254-2621: 254-262
Pancreatic cancer in hereditary pancreatitis – Consensus guidelines for prevention, screening, and treatment.
Authors: Ulrich C and members of the Third International Symposium on Hereditary Diseases
Journal: Pancreatology 2001; 1: 412-418
ESPAC-1: A European, Randomized Controlled Study of Adjuvant Chemoradiation and Chemotherapy in Resectable Pancreatic Cancer.
Authors: Neoptolemos JP, Dunn JA, Moffitt DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H and Büchler M, for the members of the European Study Group for Pancreatic Cancer (ESPAC)
Journal: Lancet 2001; 358: 1576-85
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy within the ESPAC-1 randomized controlled trial.
Authors: Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Berger HG, Pederzoli P, Bassi C, Dervernis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab F, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Büchler MW for the members of the European Study Group for Pancratic Cancer (ESPAC)
Journal: Annals of Surgery 2001; 234: 758-768
A phase II trial of marimastat in advanced pancreatic cancer.
Authors: Evans JD, Stark A, Johnson CD, Daniel F, Carmichael J, Buckels J, Imrie CW, Brown P, Neoptolemos JP
Journal: British Journal of Cancer 2001; 85: 1865-1870
Adjuvant therapy for pancreatic cancer
Authors: Ghaneh P, Slavin J, Sutton R, Neoptolemos JP
Journal: Swiss Surgery 2000; 6: 289-295
K-ras oncogene subtype mutations are associated with survival but not theexpression of p53, p16INK4a, p21WAF-1, Cyclin D1, erbb-B2 and erbb-B3 in resected pancreatic ductal adenocarcinoma.
Authors: Kawesha A, Ghaneh P, Andrén-Sandberg Å, Ögraed D, Skar R, Dawiskiba S, Evans JD, Campbell F, Lemoine N and Neoptolemos JP
Journal: International Journal of Cancer 2000; 89: 469-474
Standard Kausch-Whipple pancreatoduodenectomy.
Authors: Jones L, Russell C, Mosca F, Boggi U, Sutton R, Slavin J, Hartley M, Neoptolemos JP
Journal: Digestive Surgery 1999; 16: 297-304
A Surgical and pathological based classification of resection of pancreatic cancer: summary of an international workshop on surgical procedures in pancreatic cancer.
Authors: Pedrazzoli S, Beger H, Obertop H, Andrén-Sandberg Åke Fernandez-Cruz L, Henne-Bruns D, Lütges J, Neoptolemos JP
Journal: Digestive Surgery 1999; 16: 337-345
Adjuvant radiotherapy and follow-on chemotherapy in patients with pancreatic cancer. Results of the UK Pancreatic Cancer Group study (UKPACA-1).
Authors: Neoptolemos JP, Baker P, Johnson CD, Cunningham D, Spooner D, for the UK Pancreatic Cancer Group
Journal: GI Cancer 1998; 2: 235-245
